Benjamin Weide
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 49
- Cancer Immunotherapy and Biomarkers 25
- Cutaneous Melanoma Detection and Management 16
- CAR-T cell therapy research 16
- Immunology 35
- Immunotherapy and Immune Responses 27
- Immune Cell Function and Interaction 9
- Immune cells in cancer 5
- Co-authors
- Claus Garbe (55 shared papers)Thomas Eigentler (35 shared papers)Graham Pawelec (13 shared papers)Steve Pascolo (5 shared papers)Annette Pflugfelder (17 shared papers)Birgit Scheel (4 shared papers)Ingmar Hoerr (4 shared papers)Evelyna Derhovanessian (6 shared papers)
- Journals
- Cancer Immunology Immunotherapy (8 papers)Clinical Cancer Research (6 papers)PLoS ONE (6 papers)JDDG Journal der Deutschen Dermatologischen Gesellschaft (5 papers)Journal for ImmunoTherapy of Cancer (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Benjamin Weide
90 papers receiving 9.5k citations
Benjamin Weide's Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 5.6k
- Immunology 4.1k
- Cancer Research 1.1k
- Molecular Biology 3.1k
- Pulmonary and Respiratory Medicine 913
Countries citing papers authored by Benjamin Weide
This map shows the geographic impact of Benjamin Weide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Weide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Weide more than expected).
Fields of papers citing papers by Benjamin Weide
This network shows the impact of papers produced by Benjamin Weide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Weide. The network helps show where Benjamin Weide may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Weide, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genomic correlates of response to CTLA-4 blockade in metastatic melanoma Hit paper breakdown → | 2015 | 2275 |
| 2 | The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma Hit paper breakdown → | 2013 | 755 |
| 3 | Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma Hit paper breakdown → | 2019 | 740 |
| 4 | Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients Hit paper breakdown → | 2015 | 515 |
| 5 | Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab Hit paper breakdown → | 2016 | 497 |
| 6 | 2016 | 475 | |
| 7 | 2009 | 330 | |
| 8 | 2013 | 229 | |
| 9 | 2008 | 225 | |
| 10 | 2017 | 216 | |
| 11 | 2007 | 181 | |
| 12 | 2017 | 173 | |
| 13 | 2003 | 159 | |
| 14 | 2016 | 158 | |
| 15 | 2010 | 128 | |
| 16 | 2011 | 127 | |
| 17 | 2013 | 111 | |
| 18 | 2015 | 105 | |
| 19 | 2012 | 104 | |
| 20 | 2015 | 90 |
About Benjamin Weide
Benjamin Weide is a scholar working on Oncology, Immunology, Molecular Biology, Cancer Research and Dermatology, having authored 90 papers that have together received 9.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (27 papers), Cancer Immunotherapy and Biomarkers (25 papers), Cutaneous Melanoma Detection and Management (16 papers), CAR-T cell therapy research (16 papers), Melanoma and MAPK Pathways (15 papers), Immune Cell Function and Interaction (9 papers), Immune cells in cancer (5 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Oncology (5.6k citations), Immunology (4.1k citations), Cancer Research (1.1k citations), Molecular Biology (3.1k citations) and Pulmonary and Respiratory Medicine (913 citations). Benjamin Weide has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Claus Garbe, Thomas Eigentler, Graham Pawelec, Steve Pascolo, Annette Pflugfelder, Birgit Scheel, Ingmar Hoerr, Evelyna Derhovanessian, Hans‐Georg Rammensee and Henning Zelba. Their work appears in journals such as Cancer Immunology Immunotherapy, Clinical Cancer Research, PLoS ONE, JDDG Journal der Deutschen Dermatologischen Gesellschaft and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.